These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7778073)

  • 61. Current status of pediatric vaccines.
    Feldman WE
    Postgrad Med; 1991 Oct; 90(5):135-6, 139-40. PubMed ID: 1833727
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Severe gastroenteritis after HiB preventive vaccination?].
    Wiersbitzky S; Bruns R
    Kinderarztl Prax; 1992 May; 60(3):102. PubMed ID: 1614077
    [No Abstract]   [Full Text] [Related]  

  • 63. [Vaccine based on the capsular polysaccharide of Haemophilus influenzae type b].
    Poolman JT; Rijkers GT
    Ned Tijdschr Geneeskd; 1988 Sep; 132(38):1737-40. PubMed ID: 3262833
    [No Abstract]   [Full Text] [Related]  

  • 64. Impact of a regional Hib vaccination programme in Italy.
    Gallo G; Ciofi degli Atti ML; Cerquetti M; Piovesan C; Tozzi AE; Salmaso S
    Vaccine; 2002 Jan; 20(7-8):993-5. PubMed ID: 11803057
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The new childhood immunisation schedule.
    Elliman D; Bedford H
    Nurs Stand; 2004 Oct 20-26; 19(6):37. PubMed ID: 15544189
    [No Abstract]   [Full Text] [Related]  

  • 66. Use of Haemophilus polysaccharide vaccine in a rural clinic setting.
    Ross SA; Darby CP; Harvell J; Watson C
    J S C Med Assoc; 1988 Mar; 84(3):105-8. PubMed ID: 3258942
    [No Abstract]   [Full Text] [Related]  

  • 67. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants.
    Washburn LK; O'Shea TM; Gillis DC; Block SM; Abramson JS
    J Pediatr; 1993 Nov; 123(5):791-4. PubMed ID: 8229493
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Vaccine against Haemophilus influenzae type b. A new great achievement in the research on vaccines].
    Solberg CO; Brandtzeeg P
    Tidsskr Nor Laegeforen; 1995 May; 115(13):1597-8. PubMed ID: 7778070
    [No Abstract]   [Full Text] [Related]  

  • 69. Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B.
    Insel RA; Anderson PW
    J Immunol; 1982 Mar; 128(3):1267-70. PubMed ID: 7035561
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The adjuvant effect of synthetic oligodeoxynucleotide containing CpG motif converts the anti-Haemophilus influenzae type b glycoconjugates into efficient anti-polysaccharide and anti-carrier polyvalent vaccines.
    von Hunolstein C; Mariotti S; Teloni R; Alfarone G; Romagnoli G; Orefici G; Nisini R
    Vaccine; 2001 Apr; 19(23-24):3058-66. PubMed ID: 11312000
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Surveillance for adverse events after DTwP/Hib vaccination in Brazil: sensitivity and factors associated with reporting.
    Monteiro SA; Takano OA; Waldman EA
    Vaccine; 2010 Apr; 28(18):3127-33. PubMed ID: 20197140
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines.
    Kauppi-Korkeila M; Saarinen L; Eskola J; Käyhty H
    Clin Exp Immunol; 1998 Feb; 111(2):237-42. PubMed ID: 9486387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hib vaccination: recent paper from Finland suggests that a prolonged three dose schedule offers effective protection against disease.
    European Union Invasive Bacterial Infection Surveillance scheme
    Euro Surveill; 2005 Jan; 10(1):E050113.1. PubMed ID: 16556943
    [No Abstract]   [Full Text] [Related]  

  • 74. Progress in vaccination against hepatitis B in the Americas.
    Ropero AM; Danovaro-Holliday MC; Andrus JK
    J Clin Virol; 2005 Dec; 34 Suppl 2():S14-9. PubMed ID: 16461235
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program.
    Flannery B; Samad S; de Moraes JC; Tate JE; Danovaro-Holliday MC; de Oliveira LH; Rainey JJ
    Vaccine; 2013 Mar; 31(11):1523-8. PubMed ID: 23313652
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Validating current immunization practice with young infants.
    Lewis M; Ramsay DS; Suomi SJ
    Pediatrics; 1992 Nov; 90(5):771-3. PubMed ID: 1408553
    [No Abstract]   [Full Text] [Related]  

  • 77. New developments in vaccines.
    Daum RS; Watson B; Clark HF; Plotkin SA
    Adv Pediatr Infect Dis; 1991; 6():1-57. PubMed ID: 1647165
    [No Abstract]   [Full Text] [Related]  

  • 78. Capsular polysaccharide Haemophilus influenzae type b vaccine: clinical and immunologic responses to two vaccines.
    Barkin RM; Hendley JO; Zahradnik J; McVerry P; Samuelson JS
    Pediatr Infect Dis J; 1987 Jan; 6(1):20-3. PubMed ID: 3493475
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication.
    van Alphen L; Eijk P; Käyhty H; van Marle J; Dankert J
    Infect Immun; 1996 Mar; 64(3):995-1001. PubMed ID: 8641812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia.
    Hartkamp A; Mulder AH; Rijkers GT; van Velzen-Blad H; Biesma DH
    Vaccine; 2001 Feb; 19(13-14):1671-7. PubMed ID: 11166890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.